A prospective randomized study of the usfulness of the artery first approach in pancreatic cancer with pancreaticoduodenectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003829

Enrollment

268

Registered

2019-04-23

Start date

2020-04-29

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Patients with suspected pancreatic head cancer who were scheduled for pancreaticoduodenectomy were randomly assigned to the control group and the experimental group. A web-based

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The patients who need to undergo pancreatoduodnectomy for pancreatic head cancer 2. No systemic metastasis 3. more than 20 years old 4. Patients who can read and understand the informed consent and can express their intent to agree

Exclusion criteria

Exclusion criteria: 1. Systemic metastasis 2. Neoadjuvant chemothearpy for borderline resectable pancreatic cancer or locally advanced pancreatic cancer 3.. patients who need reconstruct artery 4. Ischemic heart disease 5. Severe liver failure, liver cirrhosis 6. Respiratory distress with oxygen therapy 7. Chronic kidney disease with hemodialysis 8. severe psychological or neurological disease 9. Drug abuse, alcoholism

Design outcomes

Primary

Measure	Time frame
The 2 year recurrence free survival rate;recurrence pattern	—

Secondary

Measure	Time frame
blood loss, interaopeative transfusion rate;overall complication;R0 resection rete;lenght of hospital stay;recurrence pattern;3 months death rate;re-operation, re-admission	—

Countries

Korea, Republic of

Contacts

Public Contactsong cheol Kim

Asan Medical Center

drksc@amc.seoul.kr+82-2-3010-3936

Outcome results